Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 120

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins

Wals, Kim, Ovaa, Huib · 2014 · Frontiers in Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fchem.2014.00015

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 87

  1. Anderson, 2002, Exploring the limits of codon and anticodon size, Chem. Biol, 9, 237, 10.1016/S1074-5521(02)00094-7 · DOI
  2. Armen, 2010, Steric and thermodynamic limits of design for the incorporation of large unnatural amino acids in aminoacyl-tRNA synthetase enzymes, Proteins, 78, 1926, 10.1002/prot.22706 · doi:10.1002/prot.22706
  3. Axup, 2012, Synthesis of site-specific antibody-drug conjugates using unnatural amino acids, Proc. Natl. Acad. Sci. U.S.A, 109, 16101, 10.1073/pnas.1211023109 · DOI · Paper page
  4. Banta, 2013, Replacing antibodies: engineering new binding proteins, Annu. Rev. Biomed. Eng, 15, 93, 10.1146/annurev-bioeng-071812-152412 · DOI
  5. Bayly, 2002, Large-scale bacterial fermentation and isolation of scFv multimers using a heat-inducible bacterial expression vector, J. Immunol. Methods, 262, 217, 10.1016/S0022-1759(02)00021-2 · DOI
  6. Bernardes, 2012, A traceless vascular-targeting antibody-drug conjugate for cancer therapy, Angew. Chem. Int. Ed. Engl, 51, 941, 10.1002/anie.201106527 · DOI
  7. Best, 2009, Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules, Biochemistry, 48, 6571, 10.1021/bi9007726 · DOI · Paper page
  8. Boder, 2000, Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity, Proc. Natl. Acad. Sci. U.S.A, 97, 10701, 10.1073/pnas.170297297 · DOI · Paper page
  9. Budisa, 2004, Prolegomena to future experimental efforts on genetic code engineering by expanding its amino acid repertoire, Angew. Chem. Int. Ed. Engl, 43, 6426, 10.1002/anie.200300646 · DOI · Paper page
  10. Cellitti, 2008, In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy, J. Am. Chem. Soc, 130, 9268, 10.1021/ja801602q · DOI · Paper page
  11. Chari, 2008, Targeted cancer therapy: conferring specificity to cytotoxic drugs, Acc. Chem. Res, 41, 98, 10.1021/ar700108g · DOI · Paper page
  12. Chatterjee, 2013, A versatile platform for single- and multiple-unnatural amino acid mutagenesis in Escherichia coli., Biochemistry, 52, 1828, 10.1021/bi4000244 · DOI · Paper page
  13. Cho, 2011, Optimized clinical performance of growth hormone with an expanded genetic code, Proc. Natl. Acad. Sci. U.S.A, 108, 9060, 10.1073/pnas.1100387108 · DOI · Paper page
  14. Cho, 2003, Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab, Nature, 421, 756, 10.1038/nature01392 · DOI · Paper page
  15. Choe, 2003, Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120, Cell, 114, 161, 10.1016/S0092-8674(03)00508-7 · DOI · Paper page
  16. Daniels, 2006, The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer, Clin. Immunol, 121, 144, 10.1016/j.clim.2006.06.010 · DOI · Paper page
  17. de Graaf, 2009, Nonnatural amino acids for site-specific protein conjugation, Bioconjug. Chem, 20, 1281, 10.1021/bc800294a · DOI · Paper page
  18. Deiters, 2004, Site-specific PEGylation of proteins containing unnatural amino acids, Bioorg. Med. Chem. Lett, 14, 5743, 10.1016/j.bmcl.2004.09.059 · DOI · Paper page
  19. de Oliveira, 1999, High-yield purification of biosynthetic human growth hormone secreted in Escherichia coli periplasmic space, J. Chromatogr. A, 852, 441, 10.1016/S0021-9673(99)00613-5 · doi:10.1016/s0021-9673(99)00613-5
  20. Dhomen, 2012, Therapeutic targeting of the epidermal growth factor receptor in human cancer, Crit. Rev. Oncog, 17, 31, 10.1615/CritRevOncog.v17.i1.40 · doi:10.1615/critrevoncog.v17.i1.40
  21. Gerdes, 2003, Experimental determination and system level analysis of essential genes in Escherichia coli MG1655, J. Bacteriol, 185, 5673, 10.1128/JB.185.19.5673-5684.2003 · DOI · Paper page
  22. Guzman, 1995, Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter, J. Bacteriol, 177, 4121, 10.1128/jb.177.14.4121-4130.1995 · DOI · Paper page
  23. Hakim, 2009, “Inclonals”: IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding system, MAbs, 1, 281, 10.4161/mabs.1.3.8492 · DOI
  24. Hendrickson, 2004, Incorporation of nonnatural amino acids into proteins, Annu. Rev. Biochem, 73, 147, 10.1146/annurev.biochem.73.012803.092429 · DOI · Paper page
  25. Hermeling, 2004, Structure-immunogenicity relationships of therapeutic proteins, Pharm. Res, 21, 897, 10.1023/B:PHAM.0000029275.41323.a6 · DOI · Paper page
  26. Hoogenboom, 2005, Selecting and screening recombinant antibody libraries, Nat. Biotechnol, 23, 1105, 10.1038/nbt1126 · DOI · Paper page
  27. Huang, 2012, Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements, J. Ind. Microbiol. Biotechnol, 39, 383, 10.1007/s10295-011-1082-9 · DOI · Paper page
  28. Isaacs, 2011, Precise manipulation of chromosomes in vivo enables genome-wide codon replacement, Science, 333, 348, 10.1126/science.1205822 · DOI · Paper page
  29. Johnson, 2012, Release factor one is nonessential in Escherichia coli, ACS Chem. Biol, 7, 1337, 10.1021/cb300229q · DOI
  30. Johnson, 2011, RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites, Nat. Chem. Biol, 7, 779, 10.1038/nchembio.657 · DOI · Paper page
  31. Jung, 2011, Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy, Curr. Opin. Biotechnol, 22, 858, 10.1016/j.copbio.2011.03.002 · DOI
  32. Junutula, 2008, Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index, Nat. Biotechnol, 26, 925, 10.1038/nbt.1480 · DOI · Paper page
  33. Kim, 2012, Synthesis of bispecific antibodies using genetically encoded unnatural amino acids, J. Am. Chem. Soc, 134, 9918, 10.1021/ja303904e · DOI · Paper page
  34. Kruszewska, 2008, Alterations in protein secretion caused by metabolic engineering of glycosylation pathways in fungi, Acta Biochim. Pol, 55, 447, 10.18388/abp.2008_3050 · doi:10.18388/abp.2008_3050
  35. Li, 2006, Optimization of humanized IgGs in glycoengineered Pichia pastoris, Nat. Biotechnol, 24, 210, 10.1038/nbt1178 · DOI · Paper page
  36. Lim, 2010, Bioorthogonal chemistry: recent progress and future directions, Chem. Commun. (Camb.), 46, 1589, 10.1039/b925931g · DOI · Paper page
  37. Liu, 2007, Crystal structure of a biosynthetic sulfo-hirudin complexed to thrombin, J. Am. Chem. Soc, 129, 10648, 10.1021/ja0735002 · DOI
  38. Liu, 2009a, Mutagenesis and evolution of sulfated antibodies using an expanded genetic code, Biochemistry, 48, 8891, 10.1021/bi9011429 · DOI
  39. Liu, 2009b, Evolution of proteins with genetically encoded “chemical warheads.”, J. Am. Chem. Soc, 131, 9616, 10.1021/ja902985e · DOI
  40. Liu, 2008, Protein evolution with an expanded genetic code, Proc. Natl. Acad. Sci. U.S.A, 105, 17688, 10.1073/pnas.0809543105 · DOI
  41. Lopes, 2010, LPS removal from an E. coli fermentation broth using aqueous two-phase micellar system, Biotechnol. Prog, 26, 1644, 10.1002/btpr.463 · doi:10.1002/btpr.463
  42. Makino, 2011, Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies, Metab. Eng, 13, 241, 10.1016/j.ymben.2010.11.002 · DOI
  43. Mazor, 2010, Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening, FEBS J, 277, 2291, 10.1111/j.1742-4658.2010.07645.x · DOI
  44. Mazor, 2008, E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display, Nat. Protoc, 3, 1766, 10.1038/nprot.2008.176 · DOI
  45. Mazor, 2007, Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli, Nat. Biotechnol, 25, 563, 10.1038/nbt1296 · DOI · Paper page
  46. Melancon, 2009, One plasmid selection system for the rapid evolution of aminoacyl-tRNA synthetases, Bioorg. Med. Chem. Lett, 19, 3845, 10.1016/j.bmcl.2009.04.007 · DOI
  47. Meldal, 2008, Cu-catalyzed azide-alkyne cycloaddition, Chem. Rev, 108, 2952, 10.1021/cr0783479 · DOI · Paper page
  48. Mukai, 2010, Codon reassignment in the Escherichia coli genetic code, Nucleic Acids Res, 38, 8188, 10.1093/nar/gkq707 · DOI · Paper page
  49. Nakamura, 2000, Codon usage tabulated from international DNA sequence databases: status for the year 2000, Nucleic Acids Res, 28, 292, 10.1093/nar/28.1.292 · DOI · Paper page
  50. Neumann, 2012, Rewiring translation—Genetic code expansion and its applications, FEBS Lett, 586, 2057, 10.1016/j.febslet.2012.02.002 · DOI
  51. Neumann, 2009, A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation, Mol. Cell, 36, 153, 10.1016/j.molcel.2009.07.027 · DOI · Paper page
  52. Neumann, 2008, Genetically encoding N(epsilon)-acetyllysine in recombinant proteins, Nat. Chem. Biol, 4, 232, 10.1038/nchembio.73 · DOI · Paper page
  53. Nguyen, 2009, Genetically encoding N(epsilon)-methyl-L-lysine in recombinant histones, J. Am. Chem. Soc, 131, 14194, 10.1021/ja906603s · DOI · Paper page
  54. Normanly, 1990, Construction of Escherichia coli amber suppressor tRNA genes. III. Determination of tRNA specificity, J. Mol. Biol, 213, 719, 10.1016/S0022-2836(05)80258-X · DOI
  55. Payne, 2011, Product development issues for PEGylated proteins, Pharm. Dev. Technol, 16, 423, 10.3109/10837450.2010.513990 · DOI
  56. Plumbridge, 1987, The effect of dam methylation on the expression of glnS in E. coli. Biochimie, 69, 539, 10.1016/0300-9084(87)90091-5 · doi:10.1016/0300-9084(87)90091-5
  57. Prescher, 2005, Chemistry in living systems, Nat. Chem. Biol, 1, 13, 10.1038/nchembio0605-13 · DOI · Paper page
  58. Rackham, 2005, A network of orthogonal ribosome x mRNA pairs, Nat. Chem. Biol, 1, 159, 10.1038/nchembio719 · DOI · Paper page
  59. Ryu, 2006, Efficient incorporation of unnatural amino acids into proteins in Escherichia coli, Nat. Methods, 3, 263, 10.1038/nmeth864 · DOI · Paper page
  60. Salinas, 2011, Tuned Escherichia coli as a host for the expression of disulfide-rich proteins, Biotechnol. J, 6, 686, 10.1002/biot.201000335 · DOI
  61. Santoro, 2002, An efficient system for the evolution of aminoacyl-tRNA synthetase specificity, Nat. Biotechnol, 20, 1044, 10.1038/nbt742 · DOI · Paper page
  62. Schwarz, 2010, A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation, Nat. Chem. Biol, 6, 264, 10.1038/nchembio.314 · DOI · Paper page
  63. Scolnick, 1968, Release factors differing in specificity for terminator codons, Proc. Natl. Acad. Sci. U.S.A, 61, 768, 10.1073/pnas.61.2.768 · DOI · Paper page
  64. Seliger, 2008, Molecular mechanisms of MHC class I abnormalities and APM components in human tumors, Cancer Immunol. Immunother, 57, 1719, 10.1007/s00262-008-0515-4 · DOI
  65. Senter, 2009, Potent antibody drug conjugates for cancer therapy, Curr. Opin. Chem. Biol, 13, 235, 10.1016/j.cbpa.2009.03.023 · DOI · Paper page
  66. Sharpless, 2002, Searching for new reactivity (Nobel lecture), Angew. Chem. Int. Ed. Engl, 41, 2024, 10.1002/1521-3773(20020617)41:12%3C2024::AID-ANIE2024%3E3.0.CO;2-O · doi:10.1002/1521-3773(20020617)41:12<2024::aid-anie2024>3.0.co;2-o
  67. Shen, 2012, Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates, Nat. Biotechnol, 30, 184, 10.1038/nbt.2108 · DOI · Paper page
  68. Stadtman, 1996, Selenocysteine, Annu. Rev. Biochem, 65, 83, 10.1146/annurev.bi.65.070196.000503 · DOI · Paper page
  69. Steer, 1999, Major anticodon-binding region missing from an archaebacterial tRNA synthetase, J. Biol. Chem, 274, 35601, 10.1074/jbc.274.50.35601 · DOI
  70. Strohl, 2009, Discovery and development of biopharmaceuticals: current issues, Curr. Opin. Biotechnol, 20, 668, 10.1016/j.copbio.2009.10.012 · DOI
  71. Takimoto, 2011, Stereochemical basis for engineered pyrrolysyl-tRNA synthetase and the efficient in vivo incorporation of structurally divergent non-native amino acids, ACS Chem. Biol, 6, 733, 10.1021/cb200057a · DOI
  72. Terra, 2012, Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design, J. Med. Microbiol, 61, 919, 10.1099/jmm.0.039438-0 · DOI
  73. Veronese, 2002, Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation, Adv. Drug Deliv. Rev, 54, 587, 10.1016/S0169-409X(02)00029-7 · DOI · Paper page
  74. Virdee, 2011, Traceless and site-specific ubiquitination of recombinant proteins, J. Am. Chem. Soc, 10.1021/ja202799r · DOI · Paper page
  75. Virdee, 2010, Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase, Nat. Chem. Biol, 6, 750, 10.1038/nchembio.426 · DOI · Paper page
  76. Wacker, 2002, N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli., Science, 298, 1790, 10.1126/science.298.5599.1790 · DOI · Paper page
  77. Wang, 2007, Evolved orthogonal ribosomes enhance the efficiency of synthetic genetic code expansion, Nat. Biotechnol, 25, 770, 10.1038/nbt1314 · DOI · Paper page
  78. Wang, 2012, Reprogramming the genetic code: from triplet to quadruplet codes, Angew. Chem. Int. Ed. Engl, 51, 2288, 10.1002/anie.201105016 · DOI
  79. Wang, 2001, Expanding the genetic code of Escherichia coli, Science, 292, 498, 10.1126/science.1060077 · DOI · Paper page
  80. Wang, 2001, A general approach for the generation of orthogonal tRNAs, Chem. Biol, 8, 883, 10.1016/S1074-5521(01)00063-1 · DOI · Paper page
  81. Wang, 2003, Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition, J. Am. Chem. Soc, 125, 3192, 10.1021/ja021381e · DOI · Paper page
  82. Winter, 2001, Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA, J. Biotechnol, 84, 175, 10.1016/S0168-1656(00)00356-4 · DOI
  83. Xie, 2005a, Adding amino acids to the genetic repertoire, Curr. Opin. Chem. Biol, 9, 548, 10.1016/j.cbpa.2005.10.011 · DOI · Paper page
  84. Xie, 2005b, An expanding genetic code, Methods, 36, 227, 10.1016/j.ymeth.2005.04.010 · DOI
  85. Young, 2011, An evolved aminoacyl-tRNA synthetase with atypical polysubstrate specificity, Biochemistry, 50, 1894, 10.1021/bi101929e · DOI · Paper page
  86. Young, 2010, An enhanced system for unnatural amino acid mutagenesis in E. coli., J. Mol. Biol, 395, 361, 10.1016/j.jmb.2009.10.030 · DOI · Paper page
  87. Zhu, 1995, Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation, J. Immunol, 155, 1903, 10.4049/jimmunol.155.4.1903 · DOI

Cited by

See all 120

Metadata

Authors
Wals, K., & Ovaa, H.
Venue
Frontiers in Chemistry
Published
2014-04-01
Volume
2
ISSN
2296-2646
Cited by
120
References
8

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins. https://app.cochat.ai/papers/10.3389/fchem.2014.00015
The paper
Wals, K., & Ovaa, H. (2014). Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins. Frontiers in Chemistry. https://doi.org/10.3389/fchem.2014.00015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.